Shot chasers: big pharma’s covid-19 boost
Economist Podcasts
00:00
Pharmaceutical Renaissance in a Pandemic
This chapter examines the changing perception of the pharmaceutical industry during the COVID-19 pandemic, focusing on the transition from criticism of drug pricing to recognition of their vital role in vaccine development. It addresses the challenges posed by vaccine nationalism and intellectual property rights while highlighting industry commitments to innovation and equitable access.
Transcript
Play full episode
